Citadel Advisors
ORTX

Citadel Advisors’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Citadel Advisors’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-95,272
Closed -$739K – 15548
2023
Q3 		$739K Sell
95,272
-30,249
-24% -$164K ﹤0.01% 7228
2023
Q2 		$651K Buy
125,521
+2,208
+2% +$11.3K ﹤0.01% 7355
2023
Q1 		$662K Sell
123,313
-106,119
-46% -$577K ﹤0.01% 7708
2022
Q4 		$851K Buy
229,432
+398
+0.2% +$1.76K ﹤0.01% 7128
2022
Q3 		$1.15M Buy
229,034
+226,893
+10,598% +$1.26M ﹤0.01% 6696
2022
Q2 		$13K Sell
2,141
-12,990
-86% -$73.3K ﹤0.01% 12529
2022
Q1 		$108K Sell
15,131
-3,813
-20% -$37.4K ﹤0.01% 12216
2021
Q4 		$250K Sell
18,944
-583
-3% -$9.64K ﹤0.01% 11358
2021
Q3 		$449K Sell
19,527
-7,024
-26% -$209K ﹤0.01% 10143
2021
Q2 		$1.17M Sell
26,551
-5,517
-17% -$307K ﹤0.01% 7955
2021
Q1 		$2.33M Buy
32,068
+27,465
+597% +$1.95M ﹤0.01% 6036
2020
Q4 		$199K Buy
4,603
+2,655
+136% +$119K ﹤0.01% 9736
2020
Q3 		$80K Sell
1,948
-133,363
-99% -$6.89M ﹤0.01% 9395
2020
Q2 		$8.12M Buy
135,311
+48,806
+56% +$4.47M ﹤0.01% 2466
2020
Q1 		$6.51M Buy
86,505
+35,917
+71% +$4.14M ﹤0.01% 2383
2019
Q4 		$6.96M Sell
50,588
-13,998
-22% -$1.7M ﹤0.01% 2649
2019
Q3 		$7.67M Buy
+64,586
New +$9.01M ﹤0.01% 2549

Other funds holding ORTX

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Citadel Advisors's ORTX Position: Q4 2023 in Review

Citadel Advisors sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q4 2023, closing a stake of 95,272 shares — an estimated $739K sold.

Citadel Advisors first reported a position in ORTX in Q3 2019 and held it in 17 quarters. The position peaked at $8.12M in Q2 2020. 47 funds tracked by Wall St. Rank hold ORTX as of Q4 2023.

  • Citadel Advisors reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q4 2023 after selling out during the quarter.
  • Citadel Advisors sold 95,272 Orchard Therapeutics plc American Depositary Shares shares in Q4 2023, an estimated $739K.
  • Citadel Advisors first reported a position in Orchard Therapeutics plc American Depositary Shares in Q3 2019 and held it in 17 quarters.
  • Citadel Advisors's Orchard Therapeutics plc American Depositary Shares position peaked at $8.12M in Q2 2020.
  • 47 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q4 2023.

Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.